FWCC Partners with Caris to Establish Tumor Profiling Program
Doctors at the LSU Health Shreveport Feist-Weiller Cancer Center will now have access to innovative, precision-medicine technology that determines the unique biological characteristics of each individual patient’s cancer tumor. Once that information is known, physicians can identify tailored chemotherapy or radiation regimens to attack it. The new capability is the result of emerging technology called tumor profiling. Feist-Weiller will partner with Caris Life Sciences to offer the breakthrough technology to cancer patients of University Health Shreveport, a clinical partner of the LSU Health Shreveport School of Medicine.
The region’s first clinical molecular profiling program will use Caris’ industry leading comprehensive tumor profiling service, Caris Molecular Intelligence TM, to enhance the clinical and research expertise of Feist-Weiller Cancer Center. It will expand the center’s personalized medicine approach to care and offer more precise treatment planning for patients. The partnership with Caris also includes clinical support, patient and physician education and system integration. It also creates a forum to pursue joint research opportunities.
Learn more about Tumor Profiling by clicking here